SCREENING FOR DEPRESSION AND ANXIETY IN CANCER-PATIENTS USING THE HOSPITAL ANXIETY AND DEPRESSIONS SCALE
SCREENING FOR DEPRESSION AND ANXIETY IN CANCER-PATIENTS USING THE HOSPITAL ANXIETY AND DEPRESSIONS SCALE
复制标题
DOI：
10.1016/0163-8343(93)90099-a
复制
发表时间：
1993-03-01
影响因子：
7
通讯作者：
CLAMON, GH
中科院分区：
文献类型：
--
作者：
CARROLL, BT;KATHOL, RG;CLAMON, GH
对930例住院和门诊癌症患者进行医院焦虑和抑郁量表（HADS）测试。86.9%（809人）参加了这次筛查。使用建议的焦虑和抑郁分量表的临界值8分，我们发现，47.6%的这一人群将需要进一步的精神病评估。23%（23.1%）的人得分为11分或更高，根据DSM-III-R标准，最有可能患有焦虑（17.7%）或抑郁（9.9%）障碍。恶性肿瘤患者和住院患者的抑郁评分更高。HADS是一种易于管理的工具，可以识别出大部分癌症患者具有高度焦虑或抑郁。然而，由于没有进行临床精神病学访谈，因此无法确定有多少比例的患者会从治疗中受益。
Nine hundred and thirty inpatients and outpatients with cancer were approached to complete the Hospital Anxiety and Depression Scale (HADS). Eight hundred and nine (86.9%) of those approached participated in this screening. Using the suggested cutoff score of 8 for the anxiety and depression subscales, we found that 47.6% of this population would warrant further psychiatric evaluation. Twenty-three percent (23.1%) had scores 11 or greater and would be the most likely to have had anxiety (17.7%) or depressive (9.9%) disorders based on DSM-III-R criteria. Patients with active malignant disease and inpatient status were more likely to have higher depression scores. The HADS was an easily administered tool that identified a large proportion of cancer patients as having high levels of anxiety or depression. However, clinical psychiatric interviews were not performed, so it is not possible to determine what proportion of patients would benefit from treatment.